These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist. Luo S; Zhangsun D; Harvey PJ; Kaas Q; Wu Y; Zhu X; Hu Y; Li X; Tsetlin VI; Christensen S; Romero HK; McIntyre M; Dowell C; Baxter JC; Elmslie KS; Craik DJ; McIntosh JM Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4026-35. PubMed ID: 26170295 [TBL] [Abstract][Full Text] [Related]
43. Ribbon α-Conotoxin KTM Exhibits Potent Inhibition of Nicotinic Acetylcholine Receptors. Marquart LA; Turner MW; Warner LR; King MD; Groome JR; McDougal OM Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31795126 [TBL] [Abstract][Full Text] [Related]
44. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244 [TBL] [Abstract][Full Text] [Related]
45. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides. Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera. Drakopoulou E; Uray K; Mezö G; Price MR; Vita C; Hudecz F J Pept Sci; 2000 Apr; 6(4):175-85. PubMed ID: 10809390 [TBL] [Abstract][Full Text] [Related]
47. Differential block of nicotinic synapses on B versus C neurones in sympathetic ganglia of frog by alpha-conotoxins MII and ImI. Tavazoie SF; Tavazoie MF; McIntosh JM; Olivera BM; Yoshikami D Br J Pharmacol; 1997 Mar; 120(6):995-1000. PubMed ID: 9134208 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes. Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642 [TBL] [Abstract][Full Text] [Related]
49. Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3. Chen J; Liang L; Ning H; Cai F; Liu Z; Zhang L; Zhou L; Dai Q Mar Drugs; 2018 Mar; 16(4):. PubMed ID: 29614714 [TBL] [Abstract][Full Text] [Related]
50. The three-dimensional structure of the analgesic alpha-conotoxin, RgIA. Clark RJ; Daly NL; Halai R; Nevin ST; Adams DJ; Craik DJ FEBS Lett; 2008 Mar; 582(5):597-602. PubMed ID: 18242183 [TBL] [Abstract][Full Text] [Related]
51. Structure-Activity Studies Reveal the Molecular Basis for GABA Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088 [TBL] [Abstract][Full Text] [Related]
52. A novel 4/6-type alpha-conotoxin ViIA selectively inhibits nAchR α3β2 subtype. Li L; Liu N; Ding R; Wang S; Liu Z; Li H; Zheng X; Dai Q Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):1023-8. PubMed ID: 26511093 [TBL] [Abstract][Full Text] [Related]
53. A novel conotoxin framework with a helix-loop-helix (Cs alpha/alpha) fold. Möller C; Rahmankhah S; Lauer-Fields J; Bubis J; Fields GB; Marí F Biochemistry; 2005 Dec; 44(49):15986-96. PubMed ID: 16331958 [TBL] [Abstract][Full Text] [Related]
54. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor. Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists. Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404 [TBL] [Abstract][Full Text] [Related]
56. Iodo-alpha-conotoxin MI selectively binds the alpha/delta subunit interface of muscle nicotinic acetylcholine receptors. Luo S; McIntosh JM Biochemistry; 2004 Jun; 43(21):6656-62. PubMed ID: 15157099 [TBL] [Abstract][Full Text] [Related]
57. Nuclear magnetic resonance solution conformation of alpha-conotoxin AuIB, an alpha(3)beta(4) subtype-selective neuronal nicotinic acetylcholine receptor antagonist. Cho JH; Mok KH; Olivera BM; McIntosh JM; Park KH; Han KH J Biol Chem; 2000 Mar; 275(12):8680-5. PubMed ID: 10722709 [TBL] [Abstract][Full Text] [Related]
58. Solution structures of two structural isoforms of CMrVIA chi/lambda-conotoxin. Kang TS; Jois SD; Kini RM Biomacromolecules; 2006 Aug; 7(8):2337-46. PubMed ID: 16903680 [TBL] [Abstract][Full Text] [Related]
59. Enhanced microwave-assisted method for on-bead disulfide bond formation: synthesis of alpha-conotoxin MII. Galanis AS; Albericio F; Grøtli M Biopolymers; 2009; 92(1):23-34. PubMed ID: 19003899 [TBL] [Abstract][Full Text] [Related]